Key result
Elevated preoperative fasting glucose predicts post-CABG mortality, with ~2.8-fold higher 30-day risk in suspected diabetes.
Why the study?
Impaired fasting glucose below the diagnostic threshold for diabetes mellitus is associated with increased mortality after percutaneous coronary interventions, but whether preoperative fasting blood glucose is associated with increased mortality after CABG needed to be determined.
Is impaired preoperative fasting blood glucose associated with increased 30-day and 1-year mortality in patients undergoing primary CABG?
Cohort (n=1,895)
Is impaired preoperative fasting blood glucose associated with increased 30-day and 1-year mortality in patients undergoing primary CABG?
Answers are grounded in this paper and cite their sources.
Preoperative impaired fasting glucose and undiagnosed diabetes mellitus are associated with an elevated risk of mortality after CABG surgery similar to that of clinical diabetes mellitus.
AIMS: Impaired fasting glucose (IFG) below the diagnostic threshold for diabetes mellitus (DM) is associated with macrovascular pathology and increased mortality after percutaneous coronary interventions. The study goal was to determine whether pre-operative fasting blood glucose (fB-glu) is associated with an increased mortality after coronary artery bypass grafting (CABG). METHODS AND RESULTS: During 2001-03, 1895 patients underwent primary CABG [clinical DM (CDM) in 440/1895; complete data on fB-glu for n=1375/1455]. Using pre-operative fB-glu, non-diabetics were categorized as having normal fB-glu (<5.6 mmol/L), IFG (5.6< or =fB-glu<6.1 mmol/L), or suspected DM (SDM) (> or =6.1 mmol/L). fB-glu was normal in 59%. The relative risks of 30 day and 1 year mortality compared with patients with normal fB-glu was 1.7 [95% confidence interval (CI): 0.5-5.5] and 2.9 (CI: 0.8-11.2) with IFG, 2.8 (CI: 1.1-7.2) and 1.9 (CI: 0.5-6.3) with SDM vs. 1.8 (CI: 0.8-4.0) and 1.6 (CI: 0.6-4.3) if CDM, respectively. The receiver operator characteristic area for the continuous variable fB-glu and 1 year mortality was 0.65 (P=0.002). CONCLUSION: The elevated risk of death after CABG surgery known previously to be associated with CDM seems also to be shared by a group of similar size that includes patients with IFG and undiagnosed DM.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2005) conducted a cohort in Patients undergoing primary coronary artery bypass grafting (CABG) (n=1,895). Preoperative impaired fasting glucose (5.6 to <6.1 mmol/L), suspected diabetes mellitus (>=6.1 mmol/L), or clinical diabetes mellitus vs. Normal preoperative fasting blood glucose (<5.6 mmol/L) was evaluated on 30-day and 1-year mortality (RR 2.9, 95% CI 0.8-11.2, p=0.002). Preoperative fasting blood glucose predicted 1-year mortality post-CABG, with elevated 30-day mortality risk in suspected diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: